Self-Administered Drugs and Biologicals Excluded from Coverage – Medical Policy Article (A47846)

 


Contractor Information

 

Contractor Name 

National Government Services, Inc. 

 

Contractor Number 

13101

MAC

CT – Part A

13102

MAC

CT – Part B

13201

MAC

NY – Part A

13202

MAC

NY – Part B

13282

MAC

NY -  Part B

13292

MAC

NY – Part B

 

Contractor Type 

MAC - Part A 

MAC - Part B

 

Article Information

 

Article ID Number 

A47846 

 

Article Type 

SAD Exclusion Article

 

Key Article 

Yes

 

Article Title 

Self-Administered Drugs and Biologicals Excluded from Coverage – Medical Policy Article 

 

AMA CPT / ADA CDT Copyright Statement

CPT codes, descriptions and other data only are copyright 2007 American Medical Association (or such other date of publication of CPT). All Rights Reserved. Applicable FARS/DFARS Clauses Apply. Current Dental Terminology, (CDT) (including procedure codes, nomenclature, descriptors and other data contained therein) is copyright by the American Dental Association.© 2002, 2004 American Dental Association. All rights reserved. Applicable FARS/DFARS apply.

 

Primary Geographic Jurisdiction 

13101

MAC

CT – Part A

13102

MAC

CT – Part B

13201

MAC

NY – Part A

13202

MAC

NY – Part B

13282

MAC

NY -  Part B

13292

MAC

NY – Part B

 

Original Article Effective Date 

07/18/2008

 

Article Revision Effective Date 

 

Article Text 

This article is effective for Jurisdiction 13 as follows:

  • Downstate New York - Part B (except Queens County): July 18, 2008.
  • Connecticut – Part B: September 1, 2008.
  • Upstate New York – Part B: September 1, 2008.
  • Queens County, New York – Part B: September 1, 2008.
  • New York and Connecticut – Part A: November 14, 2008. The content of this article is identical to coverage currently in effect, and will be transferred to J-13 contracts 13101 and 13201 on November 14, 2008.



Coverage for self-administered drugs for both Part A and Part B is determined by the MAC Contractor in each jurisdiction. HCPCS codes used under Outpatient Prospective Payment System (OPPS) are included, in addition to the codes used for Part B claims, when appropriate.

The table below lists drugs that are not covered by Medicare, the effective date of non-coverage, and the rationale. (Please see “Process for Determining Self-Administered Drug Exclusions – Medical Policy Article”). The column, “Brand Names,” provides one or more examples but may not include all brand names.

Information about drugs not separately reimbursed or not covered for reasons other than “usually self-administered,” is detailed in carrier and fiscal intermediary publications and postings available elsewhere.

 

Coverage Topic 

Prescription Drugs
 

 

Coding Information

 

No Coding Information has been entered in this section of the article.

 

Coding Table Information

 

CPT/HCPCS Codes - Table Format 

Code

Descriptor Generic Name

Descriptor Brand Name

Exclusion Effective Date

Exclusion End Date

Comments

J0135

INJECTION, ADALIMUMAB, 20 MG

Humira

12/06/2003

N/A

Non-acute subcutaneous (SC) injection by patient, weekly or every other week.

J0270

INJECTION, ALPROSTADIL, 1.25 MCG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED)

Caverject, Edex

11/14/2002

N/A

Usually self-injected by patient on an "as-needed basis".

J0275

ALPROSTADIL URETHRAL SUPPOSITORY (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED)

Muse

11/14/2002

N/A

Suppository

J0630

INJECTION, CALCITONIN SALMON, UP TO 400 UNITS

Calcimar, Miacalcin

11/14/2002

N/A

Non-acute subcutaneous (SC) injection by patient, daily or every other day.

J1324

INJECTION, ENFUVIRTIDE, 1 MG

Fuzeon

02/15/2007

N/A

Non-acute subcutaneous (SC) injection by patient, twice daily.

J1438

INJECTION, ETANERCEPT, 25 MG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED)

Enbrel

11/14/2002

N/A

Non-acute subcutaneous (SC) injection by patient, usually twice a week.

J1595

INJECTION, GLATIRAMER ACETATE, 20 MG

Copaxone

02/07/2004

N/A

Self-administration; subcutaneous 20 mg/day

J1675

INJECTION, HISTRELIN ACETATE, 10 MICROGRAMS

Supprelin

05/16/2007

N/A

Non-acute subcutaneous administration, usually once daily by patient

J1815

INJECTION, INSULIN, PER 5 UNITS

Humalog, Humulin, Iletin, Insulin Lispo, Novo Nordisk, NPH, Pork Insulin, Regular Insulin, Ultralente, Velosulin, Humulin R, Iletin II Regular Port, Insulin Purified Pork, Relion, Lente Iletin I, Novolin R, Humulin R U-500

11/14/2002

N/A

Non-acute subcutaneous (SC) injection by patient, every day.

J1817

INSULIN FOR ADMINISTRATION THROUGH DME (I.E., INSULIN PUMP) PER 50 UNITS

Humalog, Humulin, Vesolin BR, Iletin II NPH Pork, Lantus, Lispro-PFC, Novolin, Novolog, Novolog Flexpen, Novolog Mix, Relion Novolin

11/14/2002

N/A

Non-acute chronic filling of pump by patient.

J1830

INJECTION INTERFERON BETA-1B, 0.25 MG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED)

Betaseron

11/14/2002

N/A

Non-acute subcutaneous (SC) injection by patient, usually every other day.

J2170

INJECTION, MECASERMIN, 1 MG

Increlex, Iplex

02/15/2007

N/A

Non-acute subcutaneous injection twice daily by patient.

J2354

INJECTION, OCTREOTIDE, NON-DEPOT FORM FOR SUBCUTANEOUS OR INTRAVENOUS INJECTION, 25 MCG

Sandostatin

11/14/2002

N/A

Usually self-administered injections two to four times daily, depending on the indication.

J2940

INJECTION, SOMATREM, 1 MG

Protropin

11/14/2002

N/A

Non-acute subcutaneous (SC) injection by patient, several time a week.

J2941

INJECTION, SOMATROPIN, 1 MG

Genotropin

11/14/2002

N/A

Non-acute subcutaneous (SC) injection by patient, several time a week.

J3030

INJECTION, SUMATRIPTAN SUCCINATE, 6 MG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED)

Imitrex

11/14/2002

N/A

Subcutaneous (SC) injection by patient at onset of symptoms (up to two times in a 24-hour period).

J3110

INJECTION, TERIPARATIDE, 10 MCG

Forteo

12/06/2003

N/A

Non-acute, subcutaneous (SC) injection into thigh or abdomen (lower stomach area) once a day by patient using multidose prefilled delivery device (FORTEO pen - contains 28 daily doses).

J3490

UNCLASSIFIED DRUGS

Byetta (exenatide)

09/01/2006

N/A

Non-acute subcutaneous (SC) injection by patient, within the 60-minute period before morning and evening meals.

J3490

UNCLASSIFIED DRUGS

Symlin (Pramlintide acetate)

05/16/2007

N/A

Non-acute subcutaneous (SC) injection by patient, immediately prior to major meals.

J3590

UNCLASSIFIED BIOLOGICS

Kineret

05/16/2007

N/A

Non-acute subcutaneous (SC) injection by patient, every day.

J3590

UNCLASSIFIED BIOLOGICS

Peg-Intron

12/06/2003

N/A

Subcutaneous weekly administration for one year by patient.

J3590

UNCLASSIFIED BIOLOGICS

Pegasys

12/06/2003

N/A

Subcutaneous weekly administration for 48 weeks by patient.

J3590

UNCLASSIFIED BIOLOGICS

Raptiva

02/07/2004

N/A

Non-acute subcutaneous weekly injection by patient.

J3590

UNCLASSIFIED BIOLOGICS

Somavert

05/16/2007

N/A

Non-acute subcutaneous injection daily, by patient.

J9212

INJECTION, INTERFERON ALFACON-1, RECOMBINANT, 1 MCG

Infergen

12/06/2003

N/A

Subcutaneous administration three times per week for 24-48 weeks, by patient.

J9213

INTERFERON, ALFA-2A, RECOMBINANT, 3 MILLION UNITS

Roferon A

12/06/2003

N/A

Hepatitis C: Subcutaneous administration three times per week for 12 months by patient.

Hairy cell leukemia: Subcutaneous administration daily for 16 - 24 weeks and three times per week by patient.

CML: Subcutaneous daily.

J9216

INTERFERON, GAMMA 1-B, 3 MILLION UNITS

Actimmune

12/06/2003

N/A

Non-acute subcutaneous administration usually three times per week by patient.

J9218

LEUPROLIDE ACETATE, PER 1 MG

Lupron

11/14/2002

N/A

Non-acute, usually daily subcutaneous (SC) injection by patient.

Q0515

INJECTION, SERMORELIN ACETATE, 1 MICROGRAM

Geref

03/06/2006

N/A

Non-acute subcutaneous daily administration by patient.

 

Other Information

 

Revision History Explanation

Not Applicable

 

Related Documents 

 

Article(s)
A47521 - Process for Determining Self-Administered Drug Exclusions – Medical Policy Article